Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Creative Medical Technology Holdings ( (CELZ) ).
On October 29, 2025, Creative Medical Technology Holdings, Inc. entered into agreements with warrant holders to exercise existing warrants for 1,116,136 shares at $3.75 per share, generating approximately $4.2 million in gross proceeds. The company will issue new warrants for 2,790,340 shares, with the proceeds intended for working capital and general corporate purposes. The new warrants will be exercisable after stockholder approval and have a five-year term. The transaction also involves reducing the exercise price of certain previous warrants and issuing additional warrants to an investor. Roth Capital Partners, LLC acted as the financial advisor for the transaction.
The most recent analyst rating on (CELZ) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Creative Medical Technology Holdings stock, see the CELZ Stock Forecast page.
More about Creative Medical Technology Holdings
Average Trading Volume: 103,105
Technical Sentiment Signal: Sell
Current Market Cap: $8.44M
See more insights into CELZ stock on TipRanks’ Stock Analysis page.